doi: 10.1002/oby.22200 Sjstrm L, et al
A detailed study of 55,460 non-diabetic patients revealed gastroparesis rates of 6.5 per 1000 person-years in semaglutide users
They are also said to curb hunger and slow the emptying of the stomach, so you feel full faster and longer, causing you to eat less
Have already discussed GLP-1 options with their primary care provider: If your physician has discussed GLP-1 medication as potentially appropriate for your situation and you are exploring compounded options specifically, a platform with clinician oversight and multiple partner pharmacies may warrant further evaluation
Although the opioid receptor antagonist naltrexone does not cause weight loss in monotherapy, it reduces food intake when used in combination with Bupropion
The emergence of semaglutide as a powerful weight loss solution has been accompanied by shortages and supply chain disruptions